共 72 条
[1]
Ang K.K.(2008)Multidisciplinary management of locally advanced SCCHN: optimizing treatment outcomes Oncologist 13 899-910
[2]
Azad A.(2009)Cases J. Severe cutaneous toxicity following treatment with radiotherapy and cetuximab: a case report Cases J 2 25-781
[3]
Balermpas P.(2009)Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck Strahlenther Onkol 185 775-22
[4]
Hambek M.(2001)The EGFR as a target for anticancer therapy — focus on cetuximab Eur J Cancer 37 16-261
[5]
Seitz O.(2008)Severe skin reaction secondary to concomitant radiotherapy plus cetuximab Radiat Oncol 28 5-149
[6]
Baselga J.(2010)Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol Strahlenther Onkol 186 255-110
[7]
Berger B.(2008)Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck Ann Oncol 19 142-28
[8]
Belka C.(2008)Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab Strahlenther Onkol 184 105-578
[9]
Berger B.(2010)Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Lancet Oncol 11 21-515
[10]
Belka C.(2006)Radiotherapy plus cetuximab for squamous-cell carcinomas of the head and neck N Engl J Med 354 567-681